Nanobiotix SA (NBTX)
7.32
+0.06
(+0.83%)
USD |
NASDAQ |
May 17, 16:00
7.32
0.00 (0.00%)
After-Hours: 20:00
Nanobiotix Shareholders Equity (Quarterly): -2.038M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.038M |
| June 30, 2023 | -58.45M |
| June 30, 2023 | -58.45M |
| December 31, 2022 | -29.00M |
| June 30, 2022 | 1.872M |
| June 30, 2022 | 1.872M |
| December 31, 2021 | 30.33M |
| June 30, 2021 | 49.31M |
| June 30, 2021 | 49.31M |
| December 31, 2020 | 86.67M |
| June 30, 2020 | -24.96M |
| June 30, 2020 | -24.96M |
| December 31, 2019 | -2.138M |
| June 30, 2019 | 23.57M |
| June 30, 2019 | 23.57M |
| December 31, 2018 | 16.29M |
| Date | Value |
|---|---|
| June 30, 2018 | 37.35M |
| June 30, 2018 | 37.35M |
| December 31, 2017 | 52.69M |
| June 30, 2017 | 35.40M |
| June 30, 2017 | 35.40M |
| December 31, 2016 | 18.39M |
| June 30, 2016 | 30.50M |
| June 30, 2016 | 30.50M |
| December 31, 2015 | 17.07M |
| June 30, 2015 | 26.72M |
| June 30, 2015 | 26.72M |
| December 31, 2014 | 36.86M |
| June 30, 2014 | 35.25M |
| June 30, 2014 | 35.25M |
| December 31, 2013 | 4.394M |
| December 31, 2012 | 14.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-58.45M
Minimum
Jun 2023
86.67M
Maximum
Dec 2020
4.434M
Average
1.872M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 111.65M |
| Cellectis SA | 84.70M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 75.11M |
| Innate Pharma SA | 57.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.79M |
| Total Liabilities (Quarterly) | 105.83M |
| Debt to Equity Ratio | -24.67 |
| Current Ratio | 1.751 |
| Net Debt Paydown Yield | -0.91% |